Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Science Applications Intl (SAIC)

SAIC Q4 revenue falls 5% to $1.75 billion; adjusted EPS rises 2% to $2.62

Mixed Impact 3 of 5 earnings Written later

Science Applications International Corporation reported fourth-quarter fiscal 2026 revenue of $1.75 billion, down 5% from a year earlier, while adjusted diluted EPS rose 2% to $2.62 and GAAP diluted EPS fell 7% to $1.87. For the full year, revenue fell 3% to $7.26 billion, but diluted EPS rose 7% to $7.70. The company gave fiscal 2027 adjusted diluted EPS guidance of $9.50 to $9.70 and reiterated its revenue guidance of $7.0 billion to $7.2 billion.

Key points

  • Q4 net income was $85 million, down 13%, and diluted EPS was $1.87 versus $2.00 a year earlier.
  • Full-year fiscal 2026 net income was $358 million; adjusted diluted EPS was $10.75, up 18% from $9.13.
  • FY2027 guidance: revenue $7.0 billion to $7.2 billion, adjusted EBITDA $705 million to $715 million, adjusted diluted EPS $9.50 to $9.70.
  • Estimated backlog at fiscal year-end was $22.6 billion, of which $3.6 billion was funded; Q4 book-to-bill ratio was 0.3.

The filing

CompanyScience Applications Intl (SAIC)
Form8-K, current report
Filed with the SECMar 16, 2026, 6:55 AM ET
Accession number0001571123-26-000025

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.